On the public citation graph
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups
0 signed · 358 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/gcc.20186openalex-snapshot
Detection of chromosomal imbalances in retinoblastoma by matrix‐based comparative genomic hybridization
inferredcites →https://doi.org/10.1002/ijc.21901openalex-snapshot
Identification of novel oligodendroglioma‐associated candidate tumor suppressor genes in 1p36 and 19q13 using microarray‐based expression profiling
inferredcites →https://doi.org/10.1002/ijc.28836openalex-snapshot
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling
inferredcites →https://doi.org/10.1007/s00401-007-0243-4openalex-snapshot
The 2007 WHO Classification of Tumours of the Central Nervous System
inferredcites →https://doi.org/10.1007/s00401-009-0561-9openalex-snapshot
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
inferredcites →https://doi.org/10.1007/s00401-010-0647-4openalex-snapshot
Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing
inferredcites →https://doi.org/10.1007/s00401-010-0725-7openalex-snapshot
Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
inferredcites →https://doi.org/10.1007/s00401-010-0781-zopenalex-snapshot
Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
inferredcites →https://doi.org/10.1007/s00401-012-1031-3openalex-snapshot
Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
inferredcites →https://doi.org/10.1007/s00401-013-1156-zopenalex-snapshot
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis
inferredcites →https://doi.org/10.1007/s00401-013-1195-5openalex-snapshot
Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system
inferredcites →https://doi.org/10.1007/s00401-014-1315-xopenalex-snapshot
Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma
inferredcites →https://doi.org/10.1007/s00401-014-1326-7openalex-snapshot
Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma
inferredcites →https://doi.org/10.1007/s13402-011-0036-6openalex-snapshot
Gene expression in oligodendroglial tumors
inferredcites →https://doi.org/10.1016/j.ccr.2009.12.020openalex-snapshot
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
inferredcites →https://doi.org/10.1016/s1470-2045(13)70168-2openalex-snapshot
Molecular neuro-oncology in clinical practice: a new horizon
inferredcites →https://doi.org/10.1038/ng.2682openalex-snapshot
Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma
inferredcites →https://doi.org/10.1038/npre.2011.6666.1openalex-snapshot
Mining SOM expression portraits: Feature selection and integrating concepts of molecular function
inferredcites →https://doi.org/10.1038/nrneurol.2010.159openalex-snapshot
Update on molecular findings, management and outcome in low-grade gliomas
inferredcites →https://doi.org/10.1093/jnen/62.11.1118openalex-snapshot
Clinical Utility of Fluorescence In Situ Hybridization (FISH) in Morphologically Ambiguous Gliomas with Hybrid Oligodendroglial/Astrocytic Features
inferredcites →https://doi.org/10.1093/neuonc/nou138openalex-snapshot
Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trial
inferredcites →https://doi.org/10.1111/bpa.12171openalex-snapshot
I nternational S ociety of N europathology‐ H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading
inferredcites →https://doi.org/10.1111/j.1750-3639.2004.tb00495.xopenalex-snapshot
Selective Expression of a Subset of Neuronal Genes in Oligodendroglioma with Chromosome 1p Loss
inferredcites →https://doi.org/10.1158/1078-0432.ccr-08-2801openalex-snapshot
Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients
inferredcites →https://doi.org/10.1158/1078-0432.ccr-12-3002openalex-snapshot
The Definition of Primary and Secondary Glioblastoma
inferredcites →https://doi.org/10.1160/me9064openalex-snapshot
Development and Implementation of an Analysis Tool for Array-based Comparative Genomic Hybridization
inferredcites →https://doi.org/10.1186/1471-2105-10-307openalex-snapshot
Robust extraction of functional signals from gene set analysis using a generalized threshold free scoring function
inferredcites →https://doi.org/10.1186/1471-2105-12-306openalex-snapshot
Expression cartography of human tissues using self organizing maps
inferredcites →https://doi.org/10.1186/1476-4598-7-41openalex-snapshot
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
inferredcites →https://doi.org/10.1200/jco.2005.04.3414openalex-snapshot
Phase III Trial of Chemotherapy Plus Radiotherapy Compared With Radiotherapy Alone for Pure and Mixed Anaplastic Oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
inferredcites →https://doi.org/10.1200/jco.2005.04.6078openalex-snapshot
Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial
inferredcites →https://doi.org/10.1200/jco.2009.23.0805openalex-snapshot
Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
inferredcites →https://doi.org/10.1200/jco.2009.23.6497openalex-snapshot
NOA-04 Randomized Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine, Lomustine, and Vincristine or Temozolomide
inferredcites →https://doi.org/10.1200/jco.2012.43.2229openalex-snapshot
Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
inferredcites →https://doi.org/10.1200/jco.2012.43.2674openalex-snapshot
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
inferredcites →https://doi.org/10.1200/jco.2013.49.3726openalex-snapshot
Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH
inferredcites →https://doi.org/10.1212/01.wnl.0000339055.64476.cbopenalex-snapshot
α-Internexin expression identifies 1p19q codeleted gliomas
inferredcites →https://doi.org/10.1212/wnl.0b013e3182a95680openalex-snapshot
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation
inferredcites →https://doi.org/10.1371/journal.pone.0012548openalex-snapshot
The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas
inferredcites →https://doi.org/10.18632/oncotarget.1505openalex-snapshot
The genetic landscape of anaplastic astrocytoma
inferredcites →https://doi.org/10.18632/oncotarget.1765openalex-snapshot
Mutations in IDH1 , IDH2 , and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas
inferredcites →https://doi.org/10.18632/oncotarget.588openalex-snapshot
Frequent ATRX , CIC , FUBP1 and IDH1 mutations refine the classification of malignant gliomas
inferredcites →https://doi.org/10.5167/uzh-156115openalex-snapshot
Erratum to: The 2007 WHO classification of tumours of the central nervous system
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.3897/pharmacia.73.e198079zenodo-depositor-declared
1,3,4-Oxadiazole derivatives as potential anti-glioma agents: synthesis, characterization, in vitro cytotoxic activity against HS683 cells, and molecular docking
inferred← citeshttps://doi.org/10.1002/2056-4538.70045openalex-snapshot
MYCN amplification defines an aggressive phenotype in IDH‐mutant gliomas
inferred← citeshttps://doi.org/10.1002/cam4.4945openalex-snapshot
Development and validation of a leukocyte‐associated immunoglobulin‐like receptor‐1 prognostic signature for lower‐grade gliomas
inferred← citeshttps://doi.org/10.1002/cncr.31834openalex-snapshot
On high‐risk, low‐grade glioma: What distinguishes high from low?
inferred← citeshttps://doi.org/10.1002/cncr.33918openalex-snapshot
Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system
inferred← citeshttps://doi.org/10.1002/jmri.25960openalex-snapshot
Radiomics Strategy for Molecular Subtype Stratification of Lower‐Grade Glioma: Detecting IDH and TP53 Mutations Based on Multimodal MRI
inferred← citeshttps://doi.org/10.1002/jmri.26010openalex-snapshot
Radiomics strategy for glioma grading using texture features from multiparametric MRI
inferred← citeshttps://doi.org/10.1002/mco2.458openalex-snapshot
Identification of RP11‐770J1.4 as immune‐related lncRNA regulating the CTXN1–cGAS–STING axis in histologically lower‐grade glioma
inferred← citeshttps://doi.org/10.1002/mco2.70686openalex-snapshot
Isocitrate Dehydrogenase‐Mutant Astrocytomas: Risk Stratification and Therapeutic Advance
inferred← citeshttps://doi.org/10.1002/path.4894openalex-snapshot
Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua ( CIC ) loss to activation of the MAPK signalling cascade
inferred← citeshttps://doi.org/10.1007/978-3-030-04152-6_1openalex-snapshot
Pathology and Classification of Tumors of the Central Nervous System
inferred← citeshttps://doi.org/10.1007/978-3-030-27359-0_12openalex-snapshot
C-13 Hyperpolarized MR Spectroscopy for Metabolic Imaging of Brain Tumors
inferred← citeshttps://doi.org/10.1007/978-3-030-69170-7_9openalex-snapshot
Genomic Heterogeneity of Aggressive Pediatric and Adult Diffuse Astrocytomas
inferred← citeshttps://doi.org/10.1007/978-3-319-33432-5_1openalex-snapshot
Introduction and Overview of Brain Tumors
inferred← citeshttps://doi.org/10.1007/978-3-319-55466-2_25openalex-snapshot
Chemotherapy for Diffuse Low Grade Gliomas
inferred← citeshttps://doi.org/10.1007/978-3-319-55466-2_4openalex-snapshot
Molecular-Genetic Classification of Gliomas and Its Practical Application to Diagnostic Neuropathology
inferred← citeshttps://doi.org/10.1007/978-3-319-55466-2_8openalex-snapshot
The Genomics of Diffuse Low-Grade Gliomas
inferred← citeshttps://doi.org/10.1007/978-3-319-56820-1_5openalex-snapshot
Targeting EGFR in Glioblastoma: Molecular Biology and Current Understanding
inferred← citeshttps://doi.org/10.1007/978-981-15-7126-8_4openalex-snapshot
Diffuse Astrocytic and Oligodendroglial Tumors
inferred← citeshttps://doi.org/10.1007/s00234-025-03766-zopenalex-snapshot
MRI-based prediction of DNA methylation grade in IDH-mutant astrocytomas using qualitative imaging features and tumor volumetrics
inferred← citeshttps://doi.org/10.1007/s00330-018-5738-yopenalex-snapshot
Microvascular characteristics of lower-grade diffuse gliomas: investigating vessel size imaging for differentiating grades and subtypes
inferred← citeshttps://doi.org/10.1007/s00330-020-07090-3openalex-snapshot
Diffusion and perfusion MRI may predict EGFR amplification and the TERT promoter mutation status of IDH-wildtype lower-grade gliomas
inferred← citeshttps://doi.org/10.1007/s00330-020-07138-4openalex-snapshot
Main genetic differences in high-grade gliomas may present different MR imaging and MR spectroscopy correlates
inferred← citeshttps://doi.org/10.1007/s00401-015-1438-8openalex-snapshot
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO
inferred← citeshttps://doi.org/10.1007/s00401-015-1454-8openalex-snapshot
Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities
inferred← citeshttps://doi.org/10.1007/s00401-017-1774-yopenalex-snapshot
Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis
inferred← citeshttps://doi.org/10.1007/s00401-017-1781-zopenalex-snapshot
Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification
inferred← citeshttps://doi.org/10.1007/s00401-018-1913-0openalex-snapshot
cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”
inferred← citeshttps://doi.org/10.1007/s00401-019-02067-zopenalex-snapshot
FOCAD loss impacts microtubule assembly, G2/M progression and patient survival in astrocytic gliomas
inferred← citeshttps://doi.org/10.1007/s00401-020-02127-9openalex-snapshot
cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
inferred← citeshttps://doi.org/10.1007/s00401-021-02337-9openalex-snapshot
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma
inferred← citeshttps://doi.org/10.1007/s00401-023-02662-1openalex-snapshot
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma
inferred← citeshttps://doi.org/10.1007/s00415-017-8652-3openalex-snapshot
Neurological update: gliomas and other primary brain tumours in adults
inferred← citeshttps://doi.org/10.1007/s00432-020-03132-xopenalex-snapshot
A novel DNA damage response signature of IDH-mutant grade II and grade III astrocytoma at transcriptional level
inferred← citeshttps://doi.org/10.1007/s00432-021-03511-yopenalex-snapshot
A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy
inferred← citeshttps://doi.org/10.1007/s00701-016-3062-3openalex-snapshot
The new WHO 2016 classification of brain tumors—what neurosurgeons need to know
inferred← citeshttps://doi.org/10.1007/s10014-016-0260-xopenalex-snapshot
Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas
inferred← citeshttps://doi.org/10.1007/s10014-016-0265-5openalex-snapshot
Cancer metabolism as a central driving force of glioma pathogenesis
inferred← citeshttps://doi.org/10.1007/s10014-018-0321-4openalex-snapshot
Radiological characteristics based on isocitrate dehydrogenase mutations and 1p/19q codeletion in grade II and III gliomas
inferred← citeshttps://doi.org/10.1007/s10014-019-00348-9openalex-snapshot
Clinical, histopathological, and molecular analyses of IDH-wild-type WHO grade II–III gliomas to establish genetic predictors of poor prognosis
inferred← citeshttps://doi.org/10.1007/s10014-020-00363-1openalex-snapshot
Molecular characteristics and clinical outcomes of elderly patients with IDH-wildtype glioblastomas: comparative study of older and younger cases in Kansai Network cohort
inferred← citeshttps://doi.org/10.1007/s10014-022-00433-6openalex-snapshot
T2-fluid-attenuated inversion recovery mismatch sign in lower grade gliomas: correlation with pathological and molecular findings
inferred← citeshttps://doi.org/10.1007/s10014-023-00463-8openalex-snapshot
IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1007/s10014-025-00500-8openalex-snapshot
Analysis of clinical, histological, and genomic information of molecular glioblastoma in a Japanese glioma cohort
inferred← citeshttps://doi.org/10.1007/s10143-020-01326-yopenalex-snapshot
Observation versus radiotherapy with or without temozolomide in postoperative WHO grade II high-risk low-grade glioma: a retrospective cohort study
inferred← citeshttps://doi.org/10.1007/s10147-020-01628-7openalex-snapshot
Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems
inferred← citeshttps://doi.org/10.1007/s11060-017-2439-3openalex-snapshot
Patterns of care and treatment outcomes in older adults with low grade glioma: a 50-year experience
inferred← citeshttps://doi.org/10.1007/s11060-017-2637-zopenalex-snapshot
Overexpression of COX7A2 is associated with a good prognosis in patients with glioma
inferred← citeshttps://doi.org/10.1007/s11060-017-2704-5openalex-snapshot
Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas
inferred← citeshttps://doi.org/10.1007/s11060-018-03030-wopenalex-snapshot
Surgical management of lower-grade glioma in the spotlight of the 2016 WHO classification system
inferred← citeshttps://doi.org/10.1007/s11060-018-2867-8openalex-snapshot
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma
inferred← citeshttps://doi.org/10.1007/s11060-018-2957-7openalex-snapshot
Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai Molecular Diagnosis Network for CNS Tumors
inferred← citeshttps://doi.org/10.1007/s11060-019-03316-7openalex-snapshot
Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification
inferred← citeshttps://doi.org/10.1007/s11060-019-03341-6openalex-snapshot
Neurocognitive changes after awake surgery in glioma patients: a retrospective cohort study
inferred← citeshttps://doi.org/10.1007/s11060-020-03616-3openalex-snapshot
The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline
inferred← citeshttps://doi.org/10.1007/s11060-020-03677-4openalex-snapshot
Diffuse astrocytic glioma, IDH-Wildtype, with molecular features of glioblastoma, WHO grade IV: A single-institution case series and review
inferred← citeshttps://doi.org/10.1007/s11060-021-03776-wopenalex-snapshot
Impact of the extent of resection on the survival of patients with grade II and III gliomas using awake brain mapping
inferred← citeshttps://doi.org/10.1007/s11060-022-04005-8openalex-snapshot
Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of neuropathology in the management of progressive glioblastoma in adults
inferred← citeshttps://doi.org/10.1007/s11060-022-04162-wopenalex-snapshot
Standard or extended STUPP? Optimal duration of temozolomide for patients with high-grade gliomas: a retrospective analysis
inferred← citeshttps://doi.org/10.1007/s11060-024-04585-7openalex-snapshot
Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas
inferred← citeshttps://doi.org/10.1007/s11060-024-04737-9openalex-snapshot
Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance
inferred← citeshttps://doi.org/10.1007/s11060-025-05269-6openalex-snapshot
Prospective phase II clinical trial of molecular glioblastoma (historical grade 2 and 3 IDH wildtype gliomas) preliminary novel exploratory analyses
inferred← citeshttps://doi.org/10.1007/s11060-025-05364-8openalex-snapshot
Understanding the difference in symptoms and outcomes between glioblastoma patients diagnosed based on histological or molecular criteria: a retrospective cohort analysis from the Histo-Mol GBM collaborative
inferred← citeshttps://doi.org/10.1007/s11060-025-05368-4openalex-snapshot
Treatment differences in IDH–wildtype glioma – the impact of surgery and adjuvant therapy
inferred← citeshttps://doi.org/10.1007/s11060-026-05523-5openalex-snapshot
Lower-grade glioma imaging volumes and survival: a single-institution analysis of 90 patients after resection using intraoperative MRI
inferred← citeshttps://doi.org/10.1007/s11060-026-05752-8openalex-snapshot
Molecularly diagnosed glioblastoma: clinical presentation and outcomes
inferred← citeshttps://doi.org/10.1007/s11864-016-0430-4openalex-snapshot
The Role of Molecular Diagnostics in the Management of Patients with Gliomas
inferred← citeshttps://doi.org/10.1007/s11910-015-0615-4openalex-snapshot
Current Management of Adult Diffuse Infiltrative Low Grade Gliomas
inferred← citeshttps://doi.org/10.1007/s12035-015-9400-2openalex-snapshot
Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis
inferred← citeshttps://doi.org/10.1007/s12094-024-03456-xopenalex-snapshot
SEOM-GEINO clinical guidelines for grade 2 gliomas (2023)
inferred← citeshttps://doi.org/10.1007/s12672-026-04952-yopenalex-snapshot
BET1 serves as a prognostic indicator and promotes cancer proliferation in glioblastoma multiforme
inferred← citeshttps://doi.org/10.1007/s15004-016-5214-2openalex-snapshot
Drei molekulare Marker für fünf Hauptgruppen
inferred← citeshttps://doi.org/10.1007/s15005-015-1452-3openalex-snapshot
Was sind „niedriger-gradige“ Gliome?
inferred← citeshttps://doi.org/10.1007/s15005-015-1486-6openalex-snapshot
Drei molekulare Marker für fünf Hauptgruppen
inferred← citeshttps://doi.org/10.1016/b978-0-12-802395-2.00032-8openalex-snapshot
Clinical neuropathology of brain tumors
inferred← citeshttps://doi.org/10.1016/b978-0-12-802997-8.00005-0openalex-snapshot
Histologic classification of gliomas
inferred← citeshttps://doi.org/10.1016/b978-0-12-802997-8.00013-xopenalex-snapshot
Complications from radiotherapy
inferred← citeshttps://doi.org/10.1016/b978-0-12-802997-8.00021-9openalex-snapshot
Astrocytic gliomas WHO grades II and III
inferred← citeshttps://doi.org/10.1016/b978-0-12-812100-9.00033-4openalex-snapshot
Chemotherapy of Low-Grade Astrocytomas
inferred← citeshttps://doi.org/10.1016/b978-0-12-813158-9.00009-8openalex-snapshot
The role of biomarkers in the diagnosis and treatment of oligodendrogliomas
inferred← citeshttps://doi.org/10.1016/b978-0-323-69494-0.00011-7openalex-snapshot
Approach to the low-grade glioma patient
inferred← citeshttps://doi.org/10.1016/b978-0-443-27356-8.00023-1openalex-snapshot
Chemotherapy of low-grade astrocytomas
inferred← citeshttps://doi.org/10.1016/b978-2-294-75394-7.00007-2openalex-snapshot
Tumeurs cranioencéphaliques : tumeurs intra-axiales
inferred← citeshttps://doi.org/10.1016/j.acra.2020.02.017openalex-snapshot
Lower-Grade Gliomas: Predicting DNA Methylation Subtyping and its Consequences on Survival with MR Features
inferred← citeshttps://doi.org/10.1016/j.acra.2021.10.014openalex-snapshot
Radiomic Analysis of Contrast-Enhanced MRI Predicts DNA Copy-Number Subtype and Outcome in Lower-Grade Gliomas
inferred← citeshttps://doi.org/10.1016/j.bbapap.2016.11.012openalex-snapshot
Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification
inferred← citeshttps://doi.org/10.1016/j.bbrep.2018.07.003openalex-snapshot
Epitope mapping of an anti-alpha thalassemia/mental retardation syndrome X-linked monoclonal antibody AMab-6
inferred← citeshttps://doi.org/10.1016/j.brainresbull.2021.11.016openalex-snapshot
miRNA-338-3p inhibits glioma cell proliferation and progression by targeting MYT1L
inferred← citeshttps://doi.org/10.1016/j.canlet.2016.01.024openalex-snapshot
CGCG clinical practice guidelines for the management of adult diffuse gliomas
inferred← citeshttps://doi.org/10.1016/j.canlet.2020.10.050openalex-snapshot
Clinical practice guidelines for the management of adult diffuse gliomas
inferred← citeshttps://doi.org/10.1016/j.canlet.2021.09.008openalex-snapshot
Molecular subtype impacts surgical resection in low-grade gliomas: A Chinese Glioma Genome Atlas database analysis
inferred← citeshttps://doi.org/10.1016/j.cell.2022.04.038openalex-snapshot
Glioma progression is shaped by genetic evolution and microenvironment interactions
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2017.09.013openalex-snapshot
TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups—A meta-analysis of aggregate data
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2020.103062openalex-snapshot
Anaplastic Astrocytoma: State of the art and future directions
inferred← citeshttps://doi.org/10.1016/j.ctro.2018.12.003openalex-snapshot
Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas
inferred← citeshttps://doi.org/10.1016/j.ebiom.2022.104007openalex-snapshot
APOLLO: An accurate and independently validated prediction model of lower-grade gliomas overall survival and a comparative study of model performance
inferred← citeshttps://doi.org/10.1016/j.ejca.2017.10.019openalex-snapshot
Farewell to monomodality treatment in patients with WHO lower grade glioma?
inferred← citeshttps://doi.org/10.1016/j.ejca.2018.10.019openalex-snapshot
Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning
inferred← citeshttps://doi.org/10.1016/j.ejca.2020.06.018openalex-snapshot
Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas
inferred← citeshttps://doi.org/10.1016/j.ejca.2021.01.014openalex-snapshot
Telomerase reverse transcriptase promoter mutation– and O6-methylguanine DNA methyltransferase promoter methylation–mediated sensitivity to temozolomide in isocitrate dehydrogenase–wild-type glioblastoma: is there a link?
inferred← citeshttps://doi.org/10.1016/j.ejmcr.2024.100162openalex-snapshot
Stereochemistry matters: Inhibition of carbonic anhydrase II by amino acid derived sulfamates depends on their absolute configuration
inferred← citeshttps://doi.org/10.1016/j.ejso.2018.05.005openalex-snapshot
Correlation of IDH1 and B7 H3 expression with prognosis of CRC patients
inferred← citeshttps://doi.org/10.1016/j.hoc.2021.08.007openalex-snapshot
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma
inferred← citeshttps://doi.org/10.1016/j.humpath.2017.05.005openalex-snapshot
Molecular classification of adult diffuse gliomas: conflicting IDH1/IDH2, ATRX, and 1p/19q results
inferred← citeshttps://doi.org/10.1016/j.isci.2023.106815openalex-snapshot
Performance of deep learning algorithms to distinguish high-grade glioma from low-grade glioma: A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.jocn.2025.111833openalex-snapshot
Glioblastoma in New Zealand: A retrospective cohort analysis post WHO CNS 5
inferred← citeshttps://doi.org/10.1016/j.ncl.2018.04.005openalex-snapshot
Grade II and III Oligodendroglioma and Astrocytoma
inferred← citeshttps://doi.org/10.1016/j.neo.2021.05.006openalex-snapshot
Molecular subtypes based on CNVs related gene signatures identify candidate prognostic biomarkers in lung adenocarcinoma
inferred← citeshttps://doi.org/10.1016/j.neuint.2021.105256openalex-snapshot
Comprehensive analysis of the expression levels and prognostic values of PRDX family genes in glioma
inferred← citeshttps://doi.org/10.1016/j.nic.2020.09.011openalex-snapshot
Adult Primary Brain Neoplasm, Including 2016 World Health Organization Classification
inferred← citeshttps://doi.org/10.1016/j.pathol.2023.11.003openalex-snapshot
Prognostic and predictive biomarkers in central nervous system tumours: the molecular state of play
inferred← citeshttps://doi.org/10.1016/j.prp.2021.153445openalex-snapshot
IDH1105GGT single nucleotide polymorphism improves progression free survival in patients with IDH mutated grade II and III gliomas
inferred← citeshttps://doi.org/10.1016/j.rcl.2019.07.004openalex-snapshot
Adult Primary Brain Neoplasm, Including 2016 World Health Organization Classification
inferred← citeshttps://doi.org/10.1016/j.wneu.2021.04.026openalex-snapshot
Genomic Prognosticators and Extent of Resection in Molecularly Subtyped World Health Organization Grade II and III Gliomas–A Single-Institution, Nine-Year Data
inferred← citeshttps://doi.org/10.1016/j.wneu.2024.11.059openalex-snapshot
Survival Analysis of Glioblastoma: A Scientometric Perspective
inferred← citeshttps://doi.org/10.1016/j.xcrm.2023.101082openalex-snapshot
Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas
inferred← citeshttps://doi.org/10.1016/s1470-2045(16)30313-8openalex-snapshot
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
inferred← citeshttps://doi.org/10.1038/nature26000openalex-snapshot
DNA methylation-based classification of central nervous system tumours
inferred← citeshttps://doi.org/10.1038/nrclinonc.2016.204openalex-snapshot
Advances in the molecular genetics of gliomas — implications for classification and therapy
inferred← citeshttps://doi.org/10.1038/nrneurol.2015.171openalex-snapshot
Circulating biomarkers for gliomas
inferred← citeshttps://doi.org/10.1038/s41374-021-00667-6openalex-snapshot
Grading of adult diffuse gliomas according to the 2021 WHO Classification of Tumors of the Central Nervous System
inferred← citeshttps://doi.org/10.1038/s41374-021-00682-7openalex-snapshot
Phospholipase Cγ1 (PLCG1) overexpression is associated with tumor growth and poor survival in IDH wild-type lower-grade gliomas in adult patients
inferred← citeshttps://doi.org/10.1038/s41420-021-00661-3openalex-snapshot
Type V collagen alpha 1 chain promotes the malignancy of glioblastoma through PPRC1-ESM1 axis activation and extracellular matrix remodeling
inferred← citeshttps://doi.org/10.1038/s41582-019-0220-2openalex-snapshot
Genetic and molecular epidemiology of adult diffuse glioma
inferred← citeshttps://doi.org/10.1038/s41598-020-67743-7openalex-snapshot
Multivariate analysis reveals differentially expressed genes among distinct subtypes of diffuse astrocytic gliomas: diagnostic implications
inferred← citeshttps://doi.org/10.1038/s41598-021-93937-8openalex-snapshot
Prognostic stratification for IDH-wild-type lower-grade astrocytoma by Sanger sequencing and copy-number alteration analysis with MLPA
inferred← citeshttps://doi.org/10.1038/s41598-022-25928-2openalex-snapshot
Imaging features of localized IDH wild-type histologically diffuse astrocytomas: a single-institution case series
inferred← citeshttps://doi.org/10.1038/s41598-026-40485-8openalex-snapshot
Identification of an age-related monocyte-derived macrophages characteristic genes-based signature for high-grade diffuse glioma
inferred← citeshttps://doi.org/10.1038/s41598-026-42712-8openalex-snapshot
Pro-tumoral Ca2+ signaling is dependent on Slowpoke and Ca-α1T channels in Drosophila melanogaster glioma
inferred← citeshttps://doi.org/10.1038/srep24160openalex-snapshot
Deletion and low expression of NFKBIA are associated with poor prognosis in lower-grade glioma patients
inferred← citeshttps://doi.org/10.1055/b-0045-210211openalex-snapshot
18 Pathology of Spinal Cord Neoplasms
inferred← citeshttps://doi.org/10.1055/s-0038-1636430openalex-snapshot
Grading of Diffuse Astrocytic Gliomas: A Review of Studies Before and After the Advent of IDH Testing
inferred← citeshttps://doi.org/10.1055/s-0038-1641162openalex-snapshot
Practical Implications of the Updated WHO Classification of Brain Tumors
inferred← citeshttps://doi.org/10.1055/s-0039-1688911openalex-snapshot
Glioblastoma Multiforme and Genetic Mutations: The Issue Is Not Over Yet. An Overview of the Current Literature
inferred← citeshttps://doi.org/10.1055/s-0040-1701635openalex-snapshot
Importance and Evidence of Extent of Resection in Glioblastoma
inferred← citeshttps://doi.org/10.1055/s-0041-1741061openalex-snapshot
Clinical, Morphological, and Molecular Study of Diffuse WHO Grade II and III Astrocytomas: A Retrospective Analysis from a Single Tertiary Care Institute
inferred← citeshttps://doi.org/10.1073/pnas.2416024122openalex-snapshot
A clinically relevant model and method to study necrosis as a driving force in glioma restructuring and progression
inferred← citeshttps://doi.org/10.1080/00207454.2018.1516655openalex-snapshot
Expression and clinicopathological significance of Nck1 in human astrocytoma progression
inferred← citeshttps://doi.org/10.1080/2162402x.2018.1434466openalex-snapshot
Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas
inferred← citeshttps://doi.org/10.1088/1741-2552/ab8131openalex-snapshot
Artificial intelligence in glioma imaging: challenges and advances
inferred← citeshttps://doi.org/10.1089/mab.2016.0037openalex-snapshot
Establishment of Anti-Human ATRX Monoclonal Antibody AMab-6
inferred← citeshttps://doi.org/10.1093/bfgp/elw019openalex-snapshot
DNA methylation in adult diffuse gliomas
inferred← citeshttps://doi.org/10.1093/jjco/hyae151openalex-snapshot
Early progressive disease within 2 years in isocitrate dehydrogenase (IDH)–mutant astrocytoma may indicate radiation necrosis
inferred← citeshttps://doi.org/10.1093/jnen/nlaa059openalex-snapshot
Molecular Correlates of Long Survival in IDH-Wildtype Glioblastoma Cohorts
inferred← citeshttps://doi.org/10.1093/jnen/nlaa083openalex-snapshot
The Prognostic Significance of RB and PI3K Pathway Alterations in IDH-Mutant Grade II/III Astrocytomas
inferred← citeshttps://doi.org/10.1093/jnen/nlaa102openalex-snapshot
Overcoming the Odds: Toward a Molecular Profile of Long-Term Survival in Glioblastoma
inferred← citeshttps://doi.org/10.1093/jnen/nlaf039openalex-snapshot
Adult diffuse IDH-wildtype lower-grade gliomas with PDGFRA gain/amplification should be upgraded as glioblastoma
inferred← citeshttps://doi.org/10.1093/med/9780198869702.003.0005openalex-snapshot
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted
inferred← citeshttps://doi.org/10.1093/neuonc/noaa015openalex-snapshot
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients
inferred← citeshttps://doi.org/10.1093/neuonc/noaa225openalex-snapshot
Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomas
inferred← citeshttps://doi.org/10.1093/neuonc/noac194openalex-snapshot
Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: A POLA network study
inferred← citeshttps://doi.org/10.1093/neuonc/noac198openalex-snapshot
National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States
inferred← citeshttps://doi.org/10.1093/neuonc/noac217openalex-snapshot
Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000–2014 (CONCORD-3)
inferred← citeshttps://doi.org/10.1093/neuonc/noae009openalex-snapshot
Prognostic value of DNA methylation subclassification, aneuploidy, and CDKN2A/B homozygous deletion in predicting clinical outcome of IDH mutant astrocytomas
inferred← citeshttps://doi.org/10.1093/neuonc/noae164openalex-snapshot
Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors
inferred← citeshttps://doi.org/10.1093/neuonc/noaf015openalex-snapshot
The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant
inferred← citeshttps://doi.org/10.1093/neuonc/nov136openalex-snapshot
Isocitrate dehydrogenase mutations in gliomas
inferred← citeshttps://doi.org/10.1093/neuonc/nov282openalex-snapshot
Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas
inferred← citeshttps://doi.org/10.1093/neuonc/now021openalex-snapshot
Classification based on mutations ofTERTpromoter andIDHcharacterizes subtypes in grade II/III gliomas
inferred← citeshttps://doi.org/10.1093/neuonc/now133openalex-snapshot
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide
inferred← citeshttps://doi.org/10.1093/neuonc/now134openalex-snapshot
PET imaging in glioma: is it time for mainstream practice?
inferred← citeshttps://doi.org/10.1093/neuonc/now277openalex-snapshot
A clinical perspective on the 2016 WHO brain tumor classification and routine molecular diagnostics
inferred← citeshttps://doi.org/10.1093/neuonc/now285openalex-snapshot
Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma
inferred← citeshttps://doi.org/10.1093/neuonc/nox153openalex-snapshot
Identification of time-to-peak on dynamic 18F-FET-PET as a prognostic marker specifically in IDH1/2 mutant diffuse astrocytoma
inferred← citeshttps://doi.org/10.1093/neuonc/noy048openalex-snapshot
The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study
inferred← citeshttps://doi.org/10.1093/neuros/nyab136openalex-snapshot
Magnetic Resonance Imaging Parameters for Noninvasive Prediction of Epidermal Growth Factor Receptor Amplification in Isocitrate Dehydrogenase-Wild-Type Lower-Grade Gliomas: A Multicenter Study
inferred← citeshttps://doi.org/10.1093/neuros/nyy089openalex-snapshot
Malignancy Index Using Intraoperative Flow Cytometry is a Valuable Prognostic Factor for Glioblastoma Treated With Radiotherapy and Concomitant Temozolomide
inferred← citeshttps://doi.org/10.1093/neuros/nyy365openalex-snapshot
Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for Prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas?
inferred← citeshttps://doi.org/10.1093/neuros/nyy513openalex-snapshot
Radiological Characteristics and Natural History of Adult IDH-Wildtype Astrocytomas with TERT Promoter Mutations
inferred← citeshttps://doi.org/10.1093/noajnl/vdaa126openalex-snapshot
Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma
inferred← citeshttps://doi.org/10.1093/noajnl/vdae106openalex-snapshot
Exploring molecular glioblastoma: Insights from advanced imaging for a nuanced understanding of the molecularly defined malignant biology
inferred← citeshttps://doi.org/10.1093/nop/npaa037openalex-snapshot
Neuro-Oncology Practice Clinical Debate: Early treatment or observation for patients with newly diagnosed oligodendroglioma and small-volume residual disease
inferred← citeshttps://doi.org/10.1093/nop/npaa055openalex-snapshot
The cIMPACT-NOW updates and their significance to current neuro-oncology practice
inferred← citeshttps://doi.org/10.1093/oncolo/oyaf127openalex-snapshot
Clinical outcome and deep learning imaging characteristics of patients treated by radio-chemotherapy for a “molecular” glioblastoma
inferred← citeshttps://doi.org/10.1097/cco.0000000000000236openalex-snapshot
Management of diffusely infiltrating glioma in the elderly
inferred← citeshttps://doi.org/10.1097/cco.0000000000000409openalex-snapshot
Anaplastic gliomas in adults: an update
inferred← citeshttps://doi.org/10.1097/pap.0000000000000186openalex-snapshot
Incorporating Advances in Molecular Pathology Into Brain Tumor Diagnostics
inferred← citeshttps://doi.org/10.1097/pap.0000000000000194openalex-snapshot
Fluorescent In Situ Hybridization in Surgical Pathology Practice
inferred← citeshttps://doi.org/10.1097/ppo.0000000000000758openalex-snapshot
Recent Advancements and Future Perspectives on Molecular Biomarkers in Adult Lower-Grade Gliomas
inferred← citeshttps://doi.org/10.1097/rct.0000000000000816openalex-snapshot
Conventional Magnetic Resonance Features for Predicting 1p19q Codeletion Status of World Health Organization Grade II and III Diffuse Gliomas
inferred← citeshttps://doi.org/10.1097/wco.0000000000000390openalex-snapshot
Current management of low-grade gliomas
inferred← citeshttps://doi.org/10.1101/2020.09.28.316554openalex-snapshot
Medium-chain acyl-CoA dehydrogenase, a gatekeeper of mitochondrial function in glioblastoma multiforme
inferred← citeshttps://doi.org/10.1101/2021.01.20.427411openalex-snapshot
Landscape of glioblastoma niches reveals the prognostic effects of tumor-infiltrating cells
inferred← citeshttps://doi.org/10.1101/2023.09.09.23295096openalex-snapshot
Molecular Landscape and Contemporary Prognostic Signatures of Gliomas
inferred← citeshttps://doi.org/10.1101/gad.312157.118openalex-snapshot
Increased HOXA5 expression provides a selective advantage for gain of whole chromosome 7 in IDH wild-type glioblastoma
inferred← citeshttps://doi.org/10.1111/apm.12916openalex-snapshot
Biomarkers in tumors of the central nervous system – a review
inferred← citeshttps://doi.org/10.1111/bpa.12367openalex-snapshot
Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma‐Tailored Gene Panel
inferred← citeshttps://doi.org/10.1111/bpa.12801openalex-snapshot
IDH mutant lower grade (WHO Grades II/III) astrocytomas can be stratified for risk by CDKN2A, CDK4 and PDGFRA copy number alterations
inferred← citeshttps://doi.org/10.1111/cns.13654openalex-snapshot
Ferroptosis‐related gene signature predicts prognosis and immunotherapy in glioma
inferred← citeshttps://doi.org/10.1111/cns.13945openalex-snapshot
Downregulated ferroptosis‐related gene SQLE facilitates temozolomide chemoresistance, and invasion and affects immune regulation in glioblastoma
inferred← citeshttps://doi.org/10.1111/ene.13826openalex-snapshot
Prognostic significance of genetic biomarkers in isocitrate dehydrogenase‐wild‐type lower‐grade glioma: the need to further stratify this tumor entity – a meta‐analysis
inferred← citeshttps://doi.org/10.1111/nan.12928openalex-snapshot
A threshold for mitotic activity and post‐surgical residual volume defines distinct prognostic groups for astrocytoma IDH‐mutant
inferred← citeshttps://doi.org/10.1111/neup.12672openalex-snapshot
High‐grade gliomas with isocitrate dehydrogenase wild‐type and 1p/19q codeleted: Atypical molecular phenotype and current challenges in molecular diagnosis
inferred← citeshttps://doi.org/10.1146/annurev-pathol-042220-022304openalex-snapshot
DNA Methylation Profiling: An Emerging Paradigm for Cancer Diagnosis
showing the first 200 of 315 · page through all 315
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.